Cargando…
Identification of active small-molecule modulators targeting the novel immune checkpoint VISTA
BACKGROUND: Cancer immunotherapy has gained increasing popularity as a novel approach to treat cancer. A member of the B7 family, V-domain immunoglobulin suppressor of T-cell activation (VISTA) is a novel immune checkpoint that regulates a broad spectrum of immune responses. VISTA is an acidic pH-se...
Autores principales: | Li, Ting-ting, Jiang, Jing-wei, Qie, Chen-xin, Xuan, Chun-xiao, Hu, Xin-lei, Liu, Wan-mei, Chen, Wen-ting, Liu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359099/ https://www.ncbi.nlm.nih.gov/pubmed/34380434 http://dx.doi.org/10.1186/s12865-021-00446-4 |
Ejemplares similares
-
M351‐0056 is a novel low MW compound modulating the actions of the immune‐checkpoint protein VISTA
por: Hu, Xinlei, et al.
Publicado: (2021) -
Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA
por: Pan, Jing, et al.
Publicado: (2021) -
The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer
por: Xie, Xiaoxue, et al.
Publicado: (2020) -
Exploring the VISTA of microglia: immune checkpoints in CNS inflammation
por: Borggrewe, Malte, et al.
Publicado: (2020) -
Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer
por: Hou, Zelin, et al.
Publicado: (2020)